Category Archives: Healthcare

J.P. Morgan Thinks Clovis Oncology’s Stock is Going to Recover

In a report issued on October 19, Cory Kasimov from J.P. Morgan maintained a Buy rating on Clovis Oncology (NASDAQ: CLVS). The company’s shares closed on Friday at $26.36, close to its 52-week low of $26.13. According to TipRanks.com, Kasimov

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), Vertex Pharmaceuticals (NASDAQ: VRTX) and NuVasive (NASDAQ: NUVA)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Intuitive Surgical (NASDAQ:ISRG), Vertex Pharmaceuticals (NASDAQ:VRTX) and NuVasive (NASDAQ:NUVA). Intuitive Surgical (ISRG) In a report issued on October 18, Sean Lavin from BTIG

A Director at Biomerica Inc (NASDAQ: BMRA) is Buying Shares

Today, a Director at Biomerica Inc (NASDAQ: BMRA), Allen Barbieri, bought shares of BMRA for $18.75K. Following this transaction Allen Barbieri’s holding in the company was increased by 18.48% to a total of $463.2K. Following Allen Barbieri’s last BMRA Buy

Argenx Se (ARGX) Received its Third Buy in a Row

After Wedbush and Nomura gave Argenx Se (NASDAQ: ARGX) a Buy rating last month, the company received another Buy, this time from Cowen & Co. Analyst Boris Peaker maintained a Buy rating on Argenx Se today. The company’s shares opened

Clovis Oncology (CLVS) Gets a Hold Rating from Oppenheimer

In a report released today, Leah R. Cann from Oppenheimer maintained a Hold rating on Clovis Oncology (NASDAQ: CLVS). The company’s shares opened today at $30.90, close to its 52-week low of $26.21. Cann said: “The initial data for the

Cantor Fitzgerald Maintains Their Hold Rating on NuVasive (NUVA)

In a report released today, Craig Bijou from Cantor Fitzgerald maintained a Hold rating on NuVasive (NASDAQ: NUVA), with a price target of $58. The company’s shares opened today at $67.50. Bijou noted: “We maintain our Neutral rating and 12-month